Discovery offers hope of halting Motor Neurone Disease progression

October 05, 2007

Scientists have discovered a causal link between the gene for a small protein involved in the formation of blood vessels and the development of some forms of Motor Neurone Disease.

Published in the journal Human Molecular Genetics, the findings could provide a basis for developing methods for halting the progression of some forms of the disease.

Their work builds on the discovery in 2006 by a research group from Ireland that some patients have a mutated form of the gene which produces angiogenin - a protein involved in blood vessel formation.

In a series of recent papers, including the latest one in HMG, Dr Vasanta Subramanian and colleagues from the University of Bath have shown that as well as playing a key role in the formation of blood vessels, angiogenin is also involved in maintaining motor neurones.

The researchers have also discovered that the mutant versions of the molecule are toxic to motor neurones and affect their ability to grow and extend.

The scientists behind the new research believe that the gradual build up of these faulty molecules may explain the late onset and gradual deterioration of function caused by the disease.

By targeting the altered form of angiogenin, it may be possible to better maintain the neurones of people with the disease, in order to prevent them from degenerating and halt progression of the disease.

Motor Neurone Disease, which is also known as Amyotrophoic Lateral Sclerosis (ALS) affects between one-five of every 100,000 people, and around 5,000 people at any one time in the UK.

Some ALS patients of Scottish and Irish descent as well some ALS patients in the USA have the mutated gene which produces faulty angiogenin.

"We know most about angiogenin from its role in helping blood vessels branch into the tree-like structures as they grow, particularly in tumour growth," said Dr Vasanta Subramanian from the University of Bath's Department of Biology & Biochemistry.

"Last year's discovery that some patients with both familial and sporadic Motor Neurone Disease have a mutated version of the human angiogenin gene was surprising because we didn't know how angiogenin could be connected with the disease.

"Since then we have been busy trying to find out, and now we have shown that angiogenin also plays a key role in the maintenance and development of motor neurones.

"We have also found that mutated versions of this molecule are toxic to motor neurones and affect their ability to put out extensions called the axons.

"This clearer picture of how the altered angiogenin works at the cellular and molecular level enables us to think about ways of preventing the disease from progressing.

"The symptoms of Motor Neurone Disease begin to appear as the neurones which control movement begin to degenerate.

"If we can block the function of the faulty angiogenin in patients in which it is present this may help to maintain healthy neurones and prevent further progression of the disease."

Funded by the Wellcome Trust and the Medical Research Council, the researchers looked for where angiogenin is produced (expressed) in developing mouse embryos. They found that it was widely expressed in the nervous system both in the brain and in the spinal cord, mostly in the neurones.

As the mouse embryo developed, the amount of angiogenin gradually reduced but was still expressed in the brain and spinal cord of adult mice.

They then used a molecule to inhibit the activity of the angiogenin gene in neurones and discovered that the absence of angiogenin affected the neurone's ability to extend nerve projections; a process known as neurite pathfinding.

They then examined the effect of a mutated angiogenin on motor neurones and found that the molecule effects motor neurone pathfinding. They also discovered that the mutated angiogenin is toxic to motor neurones when the nerve cells are subjected to oxidative stress.

This suggests that angiogenin acts as a neurotrophic and neuroprotective factor that helps neurones to survive.

"There is still much to be done in order to better understand the precise nature of the disease mechanism and the role played by the altered forms of Angiogenin," said Dr Subramanian.

"When we figure out exactly what goes wrong, we can start to develop ways of preventing progression of this neurodegenerative disease."

In ALS, the neurones responsible for transmitting the chemical messages that enable muscle movements become affected and subsequently die, causing muscle weakness and wasting leading to death by asphyxiation.

Famous people who have succumbed to the disease include actor David Niven, footballers Don Revie and Willie Maddren, and baseball player Lou Gehrig. Professor Stephen Hawking is exceptional; he has survived with the disease for more than 35 years.

The University of Bath

---

---

	Angiogenin: Webster's Timeline History, 1985 - 2007 by Icon Group International (Author) Webster's bibliographic and event-based timelines are comprehensive in scope, covering virtually all topics, geographic locations and people. They do so from a linguistic point of view, and in the case of this book, the focus is on "Angiogenin," including when used in literature (e.g. all authors that might have Angiogenin in their name). As such, this book represents the largest compilation of timeline events associated with Angiogenin when it is used in proper noun form. Webster's timelines cover bibliographic citations, patented inventions, as well as non-conventional and alternative meanings which capture ambiguities in usage. These furthermore cover all parts of speech (possessive, institutional usage, geographic usage) and contexts, including pop culture, the arts, social sciences...
	Angiogenin i mekhanizm angiogeneza (Russian Edition) by N. P Mertvetsov (Author)
	GenVec collaborates with Cordis for delivery of angiogenic agent.: An article from: BIOTECH Patent News by Biotech Patent News (Publisher) This digital document is an article from BIOTECH Patent News, published by Biotech Patent News on February 1, 2004. The length of the article is 446 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: GenVec collaborates with Cordis for delivery of angiogenic agent. Publication: BIOTECH Patent News (Newsletter) Date: February 1, 2004 Publisher: Biotech Patent News Volume: 18 Issue: 2 Distributed by Thomson Gale
	Ribonucleases: Structures and Functions by Giuseppe D'Alessio (Editor), James F. Riordan (Editor) Pancreatic ribonuclease, the focus of highly productive scientific research for more than half a century and the only enzyme to be the basis of four Nobel prizes, has recently undergone a resurgence in popularity for the recognition of an extended ribonuclease superfamily with functions ranging from tumour growth and inhibition to self-recognition and neurotoxicity. This volume highlights the functional diversity of ribonucleases and reveals the emerging research opportunities provided by these enzymes. * Never before has discussion of the entire family of ribonucleases and related enzymes been covered in a single volume * Core chapters focus on the latest structures and functions of pancreatic-type ribonucleases * Structures and...
	Ribonucleases (Nucleic Acids and Molecular Biology) by Allen W. Nicholson (Editor) Ribonucleases are a ubiquitous and functionally diverse group of enzymes that have a common ability to cleave RNA. Either through scission of internal phosphodiesters, or removal of nucleotides from RNA 5’ or 3’ ends, ribonucleases perform essential roles in gene expression and regulation, genome replication and maintenance, host defense, stress response, and viral strategies of infection. Ribonucleases have also served as highly informative models to understand virtually every aspect of biomolecular structure and function. The fifteen chapters in this volume are written by recognized researchers in the field, and provide in-depth analyses of the major ribonuclease families. Particular focus is given to the relation of ribonuclease structure and mechanism to biological function, as...
	Progress in Nucleic Acid Research and Molecular Biology, Volume44 by Author Unknown (Editor) Provides a forum for discussion of new discoveries, approaches and ideas in molecular biology, including contributions from leaders in their fields. This volume covers such topics as the structure and action of mammalian ribonuclease (angiogenin) inhibitor.
	International Review of Cytology, Volume 161 (International Review of Cell & Molecular Biology) by Kwang W. Jeon (Editor), Jonathan Jarvik (Editor) International Review of Cytology presents current advances and comprehensive reviews in cell biology-both plant and animal. Articles address structure and control of gene expression, nucleocytoplasmic interactions, control of cell development and differentiation, and cell transformation and growth. Authored by some of the foremost scientists in the field, each volume provides up-to-date information and directions for future research.
	Nucleases: Molecular Biology and Applications by Nawin C. Mishra (Author) Nucleases are a class of enzymes that catalyze the hydrolysis of nucleic acids (DNA, RNA) in all organisms, including humans. In addition to their important biological role, nucleases have recently emerged as useful tools in laboratory studies, and have led to the development of such fields as recombinant DNA technology, molecular cloning, and genomics. Nawin Mishra’s Nucleases, the first comprehensive treatment of the subject, introduces the properties and biological roles of nucleases to newcomers in the field and provides the basis of their possible application to critical aspects of science, commerce, and industry. Covering the structure and biochemical properties of nucleases, Mishra’s text further guides the reader to understand how these enzymes can be exploited to make new...
	Angiogenesis: Models, Modulators, and Clinical Applications by Michael E. Maragoudakis (Editor) Proceedings of the 5th Biannual International Meeting on Angiogenesis: From the Molecular to Integrative Pharmacology, held July 1-7, 1999, in Crete, Greece. Angiogenesis, as a vastly complex biological process, has challenged researchers from all basic scientific disciplines, including pharmacology, biochemistry, physiology, embryology and anatomy. The significance of this phenomenon for the study of disease states has also interested clinicians from a number of specialist fields. This multidisciplinary work reflects the growth of awareness of concepts such as angiogenesis based therapy, the enormous therapeutic and commercial potential of which has attracted major research and investment in recent years. This volume, which aims to bridge the gap between basic and clinical methodology...
	International Review Of Cell and Molecular Biology, Volume 295 by Kwang W. Jeon (Editor) International Review of Cell and Molecular Biology presents current advances and comprehensive reviews in cell biology--both plant and animal. Articles address structure and control of gene expression, nucleocytoplasmic interactions, control of cell development and differentiation, and cell transformation and growth. Impact factor for 2010: 4.954.* Authored by some of the foremost scientists in the field * Provides up-to-date information and directions for future research * Valuable reference material for advanced undergraduates, graduate students and professional scientists